Riskpilot← Back to searchSign inGet full accessB&N Lang AB
ABActiveOrg 5567035091Pusshagen 106General medical practice activities · NACE 8621Est. 20060 employees
Revenue 2025
SEK 275K
-57% vs 2024
EBITDA margin
63.7%
-68% vs 2024
Equity ratio
96.2%
Financial strength
Net profit 2025
SEK 183K
-63% vs 2024
| Revenue | SEK 275K | -57% |
| EBITDA | SEK 176K | -68% |
| Net profit | SEK 183K | -63% |
| Total assets | SEK 2M | -5% |
| Equity | SEK 2M | -1% |
| Employees | 0 | — |
Legal name
B&N Lang AB
Org number
5567035091
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 maj 2006
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso- och sjukvård, friskvård samt tillhandahålla specialistkunskaper inom hälsa, kost, vård och omsorg jämte därmed förenlig verksamhet.
Address
Pusshagen 106
Email
birgitta.t.lang@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 393 | 706 | 605 | 643 | 275 |
| Staff expenses | — | −29 | −33 | −59 | −34 |
| EBITDA | 324 | 619 | 532 | 544 | 176 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 324 | 619 | 532 | 544 | 176 |
| Net financials | 1 | 1 | 6 | 82 | 56 |
| Profit before tax | 324 | 620 | 538 | 626 | 232 |
| Tax | −69 | −128 | −112 | −129 | −49 |
| Net profit | 255 | 492 | 425 | 496 | 183 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 224 | 1 619 | 1 865 | 2 147 | 2 050 |
| Equity | 1 142 | 1 451 | 1 688 | 1 990 | 1 972 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 82 | 168 | 177 | 158 | 77 |
| Total debt | 82 | 168 | 177 | 158 | 77 |
EBITDA margin
63.7%
This company
15.8%
Market median
+303% vs market
20212025
Equity ratio
96.2%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
9.3%
This company
18.4%
Market median
-49% vs market
20212025
Net profit margin
66.4%
This company
8.1%
Market median
+720% vs market
20212025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of B&N Lang AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tanja Birgitta Lang | Board of Directors | 0 companies |
| Anna Rebecka Merwani | Deputy Board Member | 0 companies |